Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration
Top Cited Papers
- 14 February 2006
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 113 (4) , 633-642.e4
- https://doi.org/10.1016/j.ophtha.2005.10.052
Abstract
No abstract availableKeywords
Funding Information
- Genentech
This publication has 11 references indexed in Scilit:
- Pegaptanib for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2004
- RISKS OF INTRAVITREOUS INJECTION: A COMPREHENSIVE REVIEWRetina, 2004
- Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured fab in complex with antigen 1 1Edited by I. A. WilsonJournal of Molecular Biology, 1999
- Cytomegalovirus retinitis in patients with acquired immune deficiency syndromePostgraduate Medical Journal, 1999
- Comparisons of the Intraocular Tissue Distribution, Pharmacokinetics, and Safety of 125I-Labeled Full-Length and Fab Antibodies in Rhesus Monkeys Following Intravitreal AdministrationToxicologic Pathology, 1999
- FomivirsenDrugs, 1999
- The Biology of Vascular Endothelial Growth FactorEndocrine Reviews, 1997
- Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.Proceedings of the National Academy of Sciences, 1995
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994
- Signs and Symptoms of Uveitis*American Journal of Ophthalmology, 1959